BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.nebraska.edu

Clinical Trials

Prevention of Osteoporosis in Breast Cancer Survivors

Not Applicable

Completed

Conditions: Postmenopausal Osteoporosis

Interventions: Other: Strength/Weight Training & Drug/Supplement
Combination Product: Drug/Supplement only

First Posted Date: 2007-12-05

Last Posted Date: 2023-11-30

Lead Sponsor: University of Nebraska

Target Recruit Count: 249

Registration Number: NCT00567606

Locations: 🇺🇸
University of Nebraska Medical Center, College of Nursing, Scottsbluff, Nebraska, United States

A Study of Thymoglobulin and Tacrolimus in Liver Transplant

Phase 4

Conditions: Liver Transplantation
Liver Disease
Immunosuppression

Interventions: Drug: tacrolimus
Drug: anti-thymocyte globulin (rabbit)

First Posted Date: 2007-11-28

Last Posted Date: 2007-11-28

Lead Sponsor: University of Nebraska

Target Recruit Count: 100

Registration Number: NCT00564538

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Study of the Effect of Calorie Supplementation on Growth in Young Children on ADHD Medication

Not Applicable

Completed

Conditions: ADHD

Interventions: Behavioral: Nutritional counseling
Dietary Supplement: Pediasure

First Posted Date: 2007-11-20

Last Posted Date: 2023-10-04

Lead Sponsor: University of Nebraska

Target Recruit Count: 29

Registration Number: NCT00561340

Locations: 🇺🇸
University of Nebraska Medical Center, Department of Psychiatry, Omaha, Nebraska, United States

Improved Induction and Maintenance Immunosuppression in Kidney Transplantation

Phase 4

Completed

Conditions: End-stage Renal Disease

Interventions: Drug: rabbit anti-thymocyte globulin - single dose
Drug: rabbit anti-thymocyte globulin - 4 doses
Drug: mycophenolate mofetil
Drug: sirolimus
Drug: tacrolimus

First Posted Date: 2007-11-12

Last Posted Date: 2023-09-18

Lead Sponsor: University of Nebraska

Target Recruit Count: 180

Registration Number: NCT00556933

Locations: 🇺🇸
Unversity of Nebraska Medical Center, Omaha, Nebraska, United States

Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase 1

Completed

Conditions: Non-Hodgkin's Lymphoma

Interventions: Drug: Dasatinib Maximum Tolerated Dose
Drug: Dasatinib

First Posted Date: 2007-10-30

Last Posted Date: 2023-09-26

Lead Sponsor: University of Nebraska

Target Recruit Count: 38

Registration Number: NCT00550615

Locations: 🇺🇸
University of Nebraska Medical Center, Internal Medicine Section of Oncology/Hematology, Omaha, Nebraska, United States

Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment

Phase 4

Completed

Conditions: Depression

Interventions: Drug: Placebo
Drug: Escitalopram

First Posted Date: 2007-09-27

Last Posted Date: 2023-09-21

Lead Sponsor: University of Nebraska

Target Recruit Count: 160

Registration Number: NCT00536172

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes

Phase 1

Terminated

Conditions: Myelodysplastic Syndromes

Interventions: Biological: filgrastim
Drug: clofarabine
Drug: cytarabine
Genetic: microarray analysis
Procedure: biopsy

First Posted Date: 2007-07-19

Last Posted Date: 2023-09-18

Lead Sponsor: University of Nebraska

Target Recruit Count: 2

Registration Number: NCT00503880

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Biological: therapeutic autologous dendritic cells
Drug: aromatase inhibition therapy
Drug: cyclophosphamide
Drug: doxorubicin hydrochloride
Drug: paclitaxel
Drug: tamoxifen citrate
Genetic: gene expression analysis
Genetic: protein expression analysis
Genetic: reverse transcriptase-polymerase chain reaction
Other: immunoenzyme technique
Other: immunohistochemistry staining method
Other: laboratory biomarker analysis
Procedure: adjuvant therapy
Procedure: biopsy
Procedure: conventional surgery
Procedure: neoadjuvant therapy
Radiation: radiation therapy

First Posted Date: 2007-07-11

Last Posted Date: 2023-09-29

Lead Sponsor: University of Nebraska

Target Recruit Count: 17

Registration Number: NCT00499083

Locations: 🇺🇸
Eppley Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida, United States

Predicting Insulin Resistance in American Indian Youth

Completed

Conditions: Insulin Resistance
Stress, Psychological

First Posted Date: 2007-07-09

Last Posted Date: 2023-09-28

Lead Sponsor: University of Nebraska

Target Recruit Count: 202

Registration Number: NCT00498030

Locations: 🇺🇸
Rosebud Indian Reservation, Rosebud, South Dakota, United States

Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer

Phase 2

Terminated

Conditions: Kidney Cancer

Interventions: Drug: Sorafenib

First Posted Date: 2007-07-04

Last Posted Date: 2023-10-26

Lead Sponsor: University of Nebraska

Target Recruit Count: 14

Registration Number: NCT00496756

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy